Department of Health Policy
Jul. 11, 2019—Medicare Part D enrollees may pay more out of pocket for high-priced specialty generic drugs than their brand-name counterparts, according to new research by health policy experts at Vanderbilt University Medical Center.
Dec. 14, 2018—Vanderbilt School of Medicine and Peabody College have established a transinstitutional Policies for Action Research Hub to better understand and develop recommendations to address the needs of some of Tennessee’s most vulnerable children, including those in immigrant families and with prenatal exposure to opioids.
Dec. 13, 2018—The findings reinforce guidelines for cautious use of antipsychotics in younger populations, according to senior author Wayne Ray.
Nov. 30, 2018—Results of the study suggest the prospect of an array of individual and societal benefits to personalized medicine, as well as risks for physical, dignitary, group, economic, psychological and legal harms, many of which may have been over-emphasized or overlooked in the literature.
Vanderbilt research hub to examine issues faced by children at risk for poor health, education outcomes
Nov. 15, 2018—Vanderbilt researchers will establish a new research hub to better understand the needs of some of some of Tennessee’s most vulnerable children.
Aug. 17, 2018—People who qualify for both Medicaid and Medicare tend to have very serious, complex health problems, but new research by Laura Keohane shows that their rate of healthcare spending is not rising any faster than that of people eligible for just Medicare.
Aug. 9, 2018—A team led by Stacie Dusetzina has received a grant to determine whether rising drug prices and out-of-pocket expenses are causing older Americans enrolled in Medicare Part D to delay or never fill their prescriptions.
Jul. 11, 2018—One of the first studies to examine the health impacts of legal marriage for LGBT individuals has found gay men were more likely to receive routine medical care following marriage legalization.
May. 24, 2018—U.S. Surgeon General Jerome Adams, MD, MPH, visited Vanderbilt University Medical Center last week to speak at the spring Health Policy Grand Rounds at Langford Auditorium. The event was dedicated to combatting America’s opioid crisis, and Adams emphasized the importance of the overdose-reversal drug naloxone.
May. 9, 2018—Generic drug options did not reduce prices paid for the cancer therapy imatinib (Gleevec), according to a Health Affairs study released this week.